Maryann Burno

A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models

Gene G. Kinney, Julie A. O’Brien, Wei Lemaire et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 299 citations

Life Sciences, Neuroscience, Pharmacology +17

Selective activation of the M ₁ muscarinic acetylcholine receptor achieved by allosteric potentiation

Lei Ma, Matthew A. Seager, Marion Wittmann et al. · Proceedings of the National Academy of Sciences · 2009 · 284 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

Metabotropic Glutamate Subtype 5 Receptors Modulate Locomotor Activity and Sensorimotor Gating in Rodents

Gene G. Kinney, Maryann Burno, Una C. Campbell et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 220 citations

Medicine, Neuroscience, Pharmacology +17

Discovery of Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 5 from a Series of <i>N</i>-(1,3-Diphenyl-1<i>H</i>- pyrazol-5-yl)benzamides That Potentiate Receptor Function in Vivo

Craig W. Lindsley, David D. Wisnoski, William Leister et al. · Journal of Medicinal Chemistry · 2004 · 171 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The Glycine Transporter Type 1 Inhibitor<i>N</i>-[3-(4′-Fluorophenyl)-3-(4′-Phenylphenoxy)Propyl]Sarcosine Potentiates NMDA Receptor-Mediated Responses<i>In Vivo</i>and Produces an Antipsychotic Profile in Rodent Behavior

Gene G. Kinney, Cyrille Sur, Maryann Burno et al. · Journal of Neuroscience · 2003 · 170 citations · Full text

Life Sciences, Neurobiology, Pharmacology +17